Henry Ji

Evaluation of SARS-CoV-2 Main Protease Inhibitors Using a Novel Cell-Based Assay

Wenyue Cao, Chia-Chuan Dean Cho, Zhi Geng et al. · ACS Central Science · 2022 · 52 citations · Full text

A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals

Yugendar R. Alugubelli, Zhi Geng, Kai S. Yang et al. · European Journal of Medicinal Chemistry · 2022 · 45 citations · Full text

Systematic Exploration, Medicine, Antiviral Drug Development +8

A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals

Yuying Ma, Kai S. Yang, Zhi Geng et al. · European Journal of Medicinal Chemistry · 2022 · 38 citations · Full text

Medicine, Antiviral Drug Development, Multi-pronged Evaluation +7

Olgotrelvir, a dual inhibitor of SARS-CoV-2 Mpro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19

Long Mao, Namir Shaabani, Xiaoying Zhang et al. · Med · 2024 · 33 citations · Full text

Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants

J. Andrew Duty, Thomas Kraus, Heyue Zhou et al. · Med · 2022 · 21 citations · Full text

Vaccination, Intranasal Administration, Vaccine Target +7